Nov 09, 2020 / 01:00PM GMT
Martin Douglas Auster - Crédit Suisse AG - Research Division - Research Analyst
I think we're live now, yes. Well, welcome to everyone who's joining us today. We're going to kick off the Credit Suisse 29th Annual Virtual -- well, first-ever virtual healthcare conference, 29th annual conference. I've got John Crowley; and Andrew Faughnan from Amicus Therapeutics to do a presentation. We have time for a few questions at the end. If anybody has any questions in the audience, please e-mail them over to me at [email protected].
Thank you very much for joining us today, John, and kicking off the conference. I'll pass it over to you.
John F. Crowley - Amicus Therapeutics, Inc. - Chairman & CEO
Great, thanks, Marty. I'll go ahead and pull up my slides, hopefully, successfully here. Can you guys see them okay?
Martin Douglas Auster - Crédit Suisse AG - Research Division - Research Analyst
Yes.
John F. Crowley - Amicus
Amicus Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot